Substrate
Topic

drug-discovery

5 stories related to this topic, newest first.

Halogenated benzofuran compounds show selective MAO-B inhibition in lab testslink.springer.com
science4 hrs ago

Halogenated benzofuran compounds show selective MAO-B inhibition in lab tests

Researchers synthesized ten halogenated benzofuran derivatives and tested their ability to inhibit monoamine oxidase enzymes. One compound, BF2, demonstrated the strongest and most selective MAO-B inhibition with a reversible mechanism.

nature.com
1 source
Two AI Systems Use Agent Teams to Generate Hypotheses and Analyze Lab DataSubstrate placeholder — needs review
ai14 days ago

Two AI Systems Use Agent Teams to Generate Hypotheses and Analyze Lab Data

Two research teams have described AI systems that coordinate multiple agents to form hypotheses, design experiments, and process results. The systems still require human oversight at key steps but completed drug-repurposing tasks in hours rather than weeks.

NA
1 source
SandboxAQ Integrates Drug Discovery Models With Claude AIprnewswire.com
ai15 days ago

SandboxAQ Integrates Drug Discovery Models With Claude AI

SandboxAQ has integrated its scientific models into Anthropic's Claude AI system. The partnership allows users to access quantitative drug discovery and materials science tools through a conversational interface.

Techcrunch
1 source
Zuckerberg and Chan Launch Biohub Initiative for AI Models of Human CellsEuronews
ai29 days ago

Zuckerberg and Chan Launch Biohub Initiative for AI Models of Human Cells

Meta CEO Mark Zuckerberg and Priscilla Chan have initiated a five-year project through Biohub to develop AI models of human cells. The effort aims to generate vast datasets for biological research, with $500 million in total funding. Data will be freely available to global resear…

Euronews
1 source
OpenAI Releases GPT-Rosalind, AI Model Tailored for Biology and Drug DiscoverySubstrate placeholder — needs review
ai46 days ago

OpenAI Releases GPT-Rosalind, AI Model Tailored for Biology and Drug Discovery

OpenAI announced GPT-Rosalind, an artificial intelligence model designed for research in biology, drug discovery, and translational medicine. The model is named after scientist Rosalind Franklin and targets scientific workflows involving molecules, proteins, and disease biology.…

Euronews
New York Post
GG
FO
TechCrunch
+9
14 sources